Concordia University Wisconsin Athletics

 

Men's Lacrosse

 
November 4, 2013

Men's Lacrosse participates in Movember, supports men's health

MEQUON, Wis. – Concordia University Wisconsin' Men's Lacrosse program is participating in the annual Movember campaign to support men's health, especially prostate and testicular cancer. The team, along with members of the Athletic Department, are growing mustaches to raise awareness.

The Falcons are selling t-shirts for $20 to help support men's cancer research and education. Please contact head coach Michael Fahey at michael.fahey@cuw.edu or at (262) 243-4547.

Click here to read more information on Movember.

Prostate Cancer Facts
In the US, one in six men will be diagnosed with prostate cancer in their lifetime making it the most frequently diagnosed cancer in men after skin cancer. In 2013, over 238,000 new cases of the disease will be diagnosed and almost 30,000 men will die of prostate cancer in the US alone.

Despite these figures, the level of awareness, understanding and support for prostate cancer lags significantly behind that of women's health causes.
* A man is 35% more likely to be diagnosed with prostate cancer than a woman is to be diagnosed with breast cancer.
* One new case of prostate cancer occurs every 2.2 minutes and a man dies from the disease every 17.5 minutes.
* The incidence rates are double for African American men.
* If detected and treated early, prostate cancer has a 97 percent success rate.

Testicular Cancer
Testicular cancer is the most common cancer in young men between the ages of 15 and 35. It starts as an abnormal growth or tumor that develops in one or both testicles. It is a highly treatable type of cancer with a very good cure rate (about 95%) if found and treated early.
* 7,920 new cases of testicular cancer are expected to be diagnosed in 2013.
* Because treatment is so successful, the risk of dying from this cancer is very low: about 1 in 5,000.
* 370 men will die from testicular cancer in 2013.
* A man's lifetime chance of having testicular cancer is about 1 in 270.